Propolis polyphenols: A review on the composition and anti-obesity mechanism of different types of propolis polyphenols

1. Introduction

Obesity is a chronic metabolic endocrine disease regulated by dietary, genetic, behavioral, and environmental factors involved in unbalanced eating pattern and energy metabolism that result in increased body fat accumulation (1). Nowadays, people are living in life style, where obesity is spreading like an “epidemic” around the world. Moreover, obesity tends to be younger and has long been a global public health crisis (2). As early as 2012, World Health Organization warned that overweight and obesity have become the fifth leading cause of death globally. Obesity itself is not fatal, but it can cause various non-communicable complications, such as hyperlipidemia, coronary heart disease, hypertension, osteoarthritis, type II diabetes, and cancer (3–7).

The underlying cause of obesity is an imbalance in the relationship between energy intake and reward-punishment mechanisms, which induce obesity (8). At present, lifestyle interventions and drugs are commonly used in the treatment of obesity. Lifestyle changes can reduce weight in the initial stage, but long-term adherence is a huge challenge. Physiological and environmental factors can cause weight regain (up to 90% weight regain) (9). Medication can be effective for weight loss, but long-term use can cause a range of side effects, such as gastrointestinal discomfort, insomnia, dizziness, and constipation (10). To date, drug-based treatments for obesity and related diseases have remained limited, either producing harmful side effects or being inefficient. Therefore, there is an urgent need for alternative “natural” remedies.

Propolis is a natural resinous complex mixture produced by honeybees that contain bioactive compounds (11). It is a traditional folk medicine used in the treatment of various diseases and has biological activities such as antibacterial, antiviral, anti-inflammatory, local anesthetic, antioxidant, immunostimulant, anti-caries and anti-cancer (11, 12). Various biological and pharmacological effects of propolis activity have been reported to be related to phenolic compounds, and propolis polyphenols have been studied for weight loss over the past few decades (13, 14). Numerous studies have reported the weight loss effects of polyphenols in propolis in animals and humans (14, 15). This article reviews the polyphenol composition of different sources of propolis, and the evidence for their anti-obesity effects, and discusses their molecular mechanisms. It is hoped that this article will improve our understanding of the weight loss effects of propolis and facilitate future research.

2. Differences in phenolic composition of different propolis types

Propolis consists of 10% volatile substances, 50%–55% resin (mainly including flavonoids, phenolic acids and esters), 30%–40% Beeswax, 5%–10% pollen and other substances (16). The chemical composition of propolis is determined by the gum source plants and is affected by season, climate, bee species, collection methods, etc. (17, 18). At present, more than 300 compounds have been identified in propolis (17). According to the different source plants of gum, it can be divided into poplar type propolis, Baccharis type propolis, Betula type propolis, Macaranga type propolis, and Dalbergia type propolis, etc. At present, the research on the anti-obesity effect of propolis mainly focuses on three types of propolis, including poplar type propolis, Baccharis type propolis, Dalbergia type propolis. The following is a description of the three main botanical sources and representative components of propolis.

2.1. Poplar-type propolis

Poplar-type propolis is the widely used and studied type of propolis, commonly distributed in Europe, North America, most of Asia and parts of North Africa (19, 20). Propolis varies in compositions, with more than 300 compounds identified as (21): (a) free phenolic acids, such as caffeic acid, p-coumaric acid and ferulic acids; (b) esters of these acids, such as caffeic acid phenethyl ester (CAPE); (c) flavonoids (flavones and flavonols) such as crysin, luteolin, apigenin, and kaempferol (21).

Figure 1 shows representative polyphenol compounds in poplar propolis. Caffeic acid and p-Coumaric acid are the main phenolic acids in water extracts of poplar propolis, with the contents reaching 76.9 ± 0.6 and 61.4 ± 0.3 mg/g, respectively (22). It is reported that caffeic acid can prevent diet induced hyperlipidemia and obesity in mice by regulating the expression of intestinal microorganisms and liver lipogenic genes (23, 24). Besides, the study found p-coumaric acid can be used against obesity by promoting thermogenesis of brown adipose tissue (25). The esters of caffeic acid, CAPE is one of the most characteristic polyphenols in ethanolic extracts of poplar propolis (about 11.2 ± 0.2 mg/g) (22). CAPE is a promising propolis ingredient. Several studies have shown that CAPE has many beneficial biological properties, including antioxidation (22), improving radiation protection (26), insulin resistance (27), and anti-obesity (28). Cardinault et al. explored the differential effects of three types of propolis alcohol extracts (Poplar, Baccharis and Dalbergia) on obesity in high-fat-fed mice, and found that only poplar propolis extract exerted a significant anti-obesity effect, suggesting that this difference may be related to its unique polyphenol compound (such as CAPE) (29). Moreover, in vivo and in vitro studies have found that CAPE can inhibit the differentiation of mouse preadipocytes and prevent adipogenesis (30, 31), and its specific mechanism will be discussed in the next chapter. In addition to phenolic acids, flavonoids, such as chrysin, galangin, apigenin and quercetin, exhibit excellent anti-obesity effects through different mechanisms (32–35).

FIGURE 1

Figure 1. Chemical structures of the representative compounds in poplar-type propolis.

2.2. Baccharis type propolis

Baccharis type propolis, mainly produced in Minas Gerais, Sao Paulo, Rio de Janeiro and Paraná in southeastern Brazil, is also known as “green propolis” due to its color ranging from greenish yellow to dark green (14). Baccharis dracunculifolia has been shown to be the most important botanical source of propolis (36, 37). Therefore, its chemical composition is very different from that of poplar-type propolis.

Figure 2 shows representative components of Baccharis type propolis. Compared with poplar-type propolis, Brazilian green propolis was also rich in Artepillin C (Art-C) and chlorogenic acid, with contents of 91.84 ± 1.16 mg/g and 19.35 ± 0.37 mg/g, respectively (38). As one of the main chemical markers of green propolis, Art-C can regulate a variety of signaling pathways to prevent the development of chronic diseases, including anti-obesity (39), anti-inflammatory (40), gastroprotective (41) and immunomodulatory (42), etc. Studies have found that Art-C plays an anti-obesity role by regulating several pathways, including affecting brown adipocyte production and promoting white adipose tissue thermogenesis (discussed in the next chapter) (39, 43). Another phenolic acid, chlorogenic acid, has also been proved to improve obesity by preventing energy balance transfer and improving lipid metabolism in obese mice fed by high-fat diet (44, 45).

FIGURE 2

Figure 2. Chemical structures of the representative compounds in Brazilian green propolis.

2.3. Dalbergia type propolis

Dalbergia propolis is mainly produced in Brazil, Cuba, Venezuela in South America and Mexico in North America (46–48). The main plant source has been determined as Dalbergia ecastaphyllum (L.) Taubert (49). This type of plant produces a red resin, which is collected by bees and used to produce propolis. Therefore, the color of Dalbergia propolis is often bright red and highly recognizable, also known as red propolis (50). Figure 3 shows the chemical structures of the representative phenolic compounds found in ethanol extract of red propolis. The main components of Dalbergia propolis are flavonoids (including flavanids, isoflavones and dihydroflavonoids) (51, 52). Isoflavones are the most abundant characteristic compounds of Dalbergia propolis different from poplar type and green propolis, Bueno-Silva et al. indicated that formononetin is the most abundant compound in Brazilian red propolis and resin, at 112.78 ± 9.07 μg/g and 77.4 ± 1.05 μg/g, respectively (53). They play a role in different physiological processes and play a variety of functions, including anti-obesity (54), anti-bacterial (55), anti-inflammatory and anti-cancer effects (52). Marcelle F. Prata and co-workers explored the effect of extract of Brazilian red propolis (mainly contained isoflavones) on hypolipidemic and anti-obesity in dyslipidemia mice model, and found that the extract of Brazilian red propolis had a hypolipidemic effect on rodent models with dyslipidemia, and minimized the effects of high-fat diet on body weight parameters and abdominal fat accumulation in mice (56). In addition, in vitro experiments showed that the ethanolic extracts of Brazilian red propolis could affect the differentiation of 3T3-L1 preadipocyte cells and the expression of adipokine (54). Although there are few studies, it can be found that red propolis extract has a promising future as a dietary supplement for the prevention and treatment of obesity and obesity-related diseases.

FIGURE 3

Figure 3. Chemical structures of the representative compounds in Brazilian red propolis.

3. Mechanisms of anti-obesity by propolis polyphenols

Currently, most studies on propolis against obesity used cellular or animal models, but there are very few clinical studies on the subject. This section identified 26 preclinical and 2 clinical studies, focusing on the effects of propolis and its extracts on obesity and summarized their anti-obesity mechanisms (Table 1).

TABLE 1

Table 1. Preclinical and clinical studies investigating the effect of propolis in anti-obesity.

3.1. Affects adipogenesis, fat accumulation and lipid metabolism

So far, numerous in vitro and in vivo studies have demonstrated that propolis affects body weight and adipose tissue weight in obese animals by affecting adipogenesis, fat accumulation and lipid metabolism (Figure 4). Ichi et al. reported that feeding pellets containing 0.5% (w/w) Brazilian propolis for 8 weeks reduced fat accumulation and serum cholesterol and triglyceride levels in high-fat-fed rats (57). In addition, propolis intake also affected lipid metabolism-related proteins in mice, such as peroxisome proliferator-activated receptor alpha (PPAR α), sterol-regulatory element binding protein 1 (SREBP-1), and 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA), therefore, propolis may improve body fat accumulation and dyslipidemia by affecting the expression of fat accumulation and lipid metabolism-related proteins (57), which was the same result as another report (59). Therapeutic effects of Brazilian propolis extract on anti-obesity and dyslipidemia have also been observed in a single-gene mutant obesity model (60). Besides Brazilian propolis, propolis from other geographical areas also has weight loss effects. For example, Chinese propolis reduced the body weight of high-fat diet mice in a dose-dependent manner and reversed the liver weight loss and triglyceride accumulation associated with liver steatosis (62); Oral administration of ethanolic extract of Croatian propolis (50 mg/kg, for 30 days) was also shown to reduce body weight and hepatic lipid accumulation in high-fat diet C57BL\6N mice, and improve mouse plasma atherogenic index (61). However, although the intervention of propolis is related to the increase of lipid metabolism related proteins, as a mixture, the details of how specific components of propolis affect the lipid metabolism of the body are still unknown. Consequently, the anti-obesity effect of propolis-derived chemicals (such as CAEP) was investigated. Several studies have found that CAPE inhibits adipocyte differentiation. For example, CAPE can significantly inhibit the expression of proteins related to lipid metabolism in adipocytes, such as PPAR-γ, adipocyte-specific fatty acid binding protein (aP2), C/EBP-α and fatty acid synthase, thereby reducing the deposition of triglycerides in 3T3-L1 cells after MDI stimulation (30, 31). The molecular mechanism by which CAPE inhibits adipocyte differentiation has also been investigated. Shin et al. found that 40 μM CAPE delayed the cell cycle progression of MDI-stimulated 3T3-L1 cells, thereby inhibiting mitotic clonal expansion (28). At the same time, CAPE also blocked the phosphorylation of ERK and Akt in 3T3-L1 cells, resulting in the inhibition of the expression of cyclin D1 downstream (31, 77). Therefore, CAPE can inhibit fat production by interfering with the early phase of fat production.

FIGURE 4

Figure 4. Effects of propolis-derived compounds on adipogenesis, fat accumulation and lipid metabolism. Caffeic acid phenethyl ester (CAPE) represses clonal expansion by disturbing the ERK/Akt-cyclin D1 cascade. Propolis may improve body fat accumulation and dyslipidemia by affecting the expression of fat accumulation and lipid metabolism-related proteins, such as peroxisome proliferator-activated receptor α (PPAR α) Sterol-regulatory element binding protein-1(SREBP-1), SREBP-2, and 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). Artepillin C exert anti-obesity effects by suppressing CREB/CRTC2-mediated both gluconeogenic and SREBP transcriptions.

Although some characteristic compounds in propolis have been reported to ameliorate metabolic syndrome, it remains a serious challenge to identify new targets of propolis active compounds and explore their underlying mechanisms. Recently, a new molecular target of propolis to improve metabolic syndrome has been found, that is, Art-C protects mice from obesity induced by high-fat diet, enhances insulin sensitivity and improves glucose and lipid metabolism by inhibiting CREB/CRTC2-mediated both gluconeogenic and SREBP transcription (63). Excitedly, Art-C has been designed and modified to form a new compound A57, which shows higher inhibitory activity on CREB-CRTC2 association and better ability to improve insulin sensitivity in obese animals (63).

3.2. Affect the expression of adipocytokine

For a long time, it was thought that the fat is simply a place to store fat. Recent studies have shown that adipocytes have a secretory function and can secrete various physiologic active substances, which are collectively known as adipocytokine. At present, the recognized adipocytokine can be divided into two categories: one is specifically expressed in adipose tissue, such as leptin and adiponectin; The other is non-specific expression of adipose tissue, such as tumor necrosis factor (TNF α) and interleukin-6 (IL-6). Research has shown that propolis and its extract can play an anti-obesity role by influencing the secretion of adipocytokine (Figure 5).

FIGURE 5

Figure 5. Proposed mechanisms demonstrating the role of propolis-derived compounds in the regulation of adipocytes lipid metabolism via induction of PPARs, adiponectin and leptin. Restore the function of mast adipocytes by reducing inflammatory cytokines. Propolis polyphenols may promote the expression of fatty acid oxidation gene (Ppara, Cpt1a, Atgl, Mcad, and Lcad) and white adipose tissue browning gene (Ucp1, Ppargc1a Prdm16 and Cidea) by activating Nrf2 pathway, while reducing the expression of inflammation gene (Tnfa, Ccl5 and Ccl2); Chrysin may inhibit I-kappa-B kinase epsilon (IKK ε) and TANK-binding kinase 1 (TBK1) to reduce the expression of key adipogenesis genes and inflammation genes, thereby reducing adipogenesis and inflammation.

Leptin acts on the weight regulation center of the hypothalamus, leading to decreased appetite and increased energy consumption, thereby reducing fat deposits and inhibiting body weight gain (78). Kohei et al. studied the effect of Brazilian green propolis ethanol extract (EEGP) on leptin expression in vivo and in vitro, and found that EEGP (100 μg/ml) significantly increased the leptin expression of 3T3-L1 adipocytes (64). Similarly, intraperitoneal injection of EEGP (100 mg/kg, twice a week for 5 weeks) strongly inhibited the feeding of C57BL/6 mice, and tripled the leptin expression in epididymal adipose tissue (64). However, another report describes the effect of CAPE on leptin expression in 3T3-L1 adipocytes (31). CAPE inhibited leptin expression in 3T3-L1 cells in a dose-dependent manner (31), and accompanied by the down-regulation of insulin receptor substrate-1 (IRS-1) (31), which is a prerequisite for adipocyte differentiation (79). Hence, the CAPE-induced leptin reduction in 3T3-L1 cells appears to be due to insufficient cell differentiation. Actually, obesity also has a persistent increase in leptin that produces leptin resistance, affects glucose intolerance, and will become a determinant of diabetes, so for this type of obesity, controlling leptin as an intervention target may have the opportunity to prevent various chronic diseases (66). In a quasi-experimental study, subjects with central obesity and normal weight were collected to determine whether honey and propolis can decrease leptin levels in patients with central obesity (15). The study found that honey and propolis can reduce leptin levels in participants with central obesity, indicating that these bee products may become dietary supplements for patients with central obesity (15).

Besides, propolis and propolis-derived chemicals also modulate the expression of other adipokines (Table 1). Adiponectin is a beneficial adipokine that can regulate energy homeostasis, glucose metabolism, and fat metabolism in organisms (80). It was found that ethanolic extract of Brazilian red propolis (EERP, 20 μg/ml for 3 days) may activate the adiponectin promoter through PPARγ, thereby promoting the expression of adiponectin mRNA in post-confluent 3T3-L1 preadipocytes (54). The same report also demonstrated that EERP also reversed the inhibiting effect of TNF-α on adiponectin expression in differentiated 3T3-L1 cells (54). Other studies have also reported the up-regulation of adiponectin in adipocytes by other propolis derivatives. For example, Art-C (10 or 25 μM) significantly enhanced adiponectin expression (1.5–2.0-fold) in 3T3-L1 cells (67, 68). Furthermore, although CAPE (10 μM) decreased leptin expression, it more than doubled adiponectin expression in human ASC-derived adipocytes (65). Taken together, several polyphenolic compounds in propolis positively regulate adiponectin expression in adipocytes.

Apart from the beneficial adipokines, propolis can affect harmful adipokine expression. CAPE (10 μM) attenuated LPS-mediated effects and significantly down-regulated the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-8) in ASC-derived adipocytes (65). In addition, in differentiated 3T3-L1 cells, CAPE had a significant inhibitory effect on TNF-α as well, although a higher dose (50 μM) was required (31). It was found in the same report that CAPE (25 or 50 μM) also decreased resistin mRNA and intracellular protein levels in 3T3-L1 cells (31). Recently, studies have shown that propolis polyphenols may play an anti-obesity role with the Nrf2 pathway, I-kappa-B kinase epsilon (IKK ε) and TANK binding kinase 1 (TBK1). Cardinault et al. studied the preventive effect of ethanol extract of poplar propolis (PPEE) on obesity and related metabolic diseases (69). The results showed that PPEE could prevent diet induced obesity, improve glucose homeostasis, promote lipid metabolism and thermogenesis, and significantly reduce the expression of inflammatory genes (such as Tnfa, Ccl5 and Ccl2), accompanied by the activation of Nrf2 pathway (69). Another study found that Chrysin can reduce hepatic IKK ε/TBK1 expression, promote triglyceride hydrolysis and oxidation, inhibit fat production and inflammation, indicating IKK ε/TBK1 may be one of the pathways of chrysin’s anti-inflammatory and insulin sensitivity (70). Nevertheless, the propolis and its derivatives reported in the above study have a regulatory effect on the two pathways of Nrf2 and IKK ε/TBK1, but the specific targets it acts on, and how to exert anti-obesity effects through specific targets in the pathway, are unknown. Moreover, a triple-blind randomized clinical trial involving 54 male military cadets reported that propolis intervention effectively reduced the oxidative stress and inflammation (IL-6, IL-10) of the subjects after vigorous activities, demonstrate that supplementation with propolis might have beneficial effects on oxidative stress and inflammation status following intense physical activities while not affecting athletic performance in healthy active subjects (71).

3.3. Induction of brown/beige adipocytes

Mammals have two types of adipose tissue with distinct physiological functions, namely white adipose tissue (WAT) and brown adipose tissue (BAT): WAT stores excess energy in the form of ATP, while BAT is characterized by the expression of thermogenic uncoupling proteins 1 (UCP1) promotes calorie production to consume excess energy, thereby inhibiting weight gain and metabolic disease (81). Recent studies have shown that brown-like adipocytes, also known as beige or brite cells, are an inducible form of brown adipocytes present in white adipose tissue that share many biochemical and morphological features with brown adipocytes (82, 83). Since these cells are innately capable of releasing excess energy, a new strategy to induce brown/beige adipocytes in WAT may be one of the most feasible approaches to prevent and treat obesity and related diseases (84, 85). This has also brought attention to dietary factors or other diet-derived factors that may contribute to the induction of brown/beige adipocyte proliferation. Recent studies have found that Brazilian propolis-derived such as Art-C, can achieve anti-obesity effects by inducing browning and thermogenesis of white adipocytes (Figure 6).

FIGURE 6

Figure 6. Artepillin C (Art C) induces brown-like adipocytes by activating peroxisome proliferator-activated receptor γ (PPAR γ) and stabilizing PRD1-BF-1-RIZ1 homologous domain-containing protein-16 (PRDM16); Art C significantly promotes the expression of genes related (UCP1, Cidea, Cox8b, and Elovl3) to brown adipocytes to induce browning of white adipose tissue, and promotes adipocyte thermogenesis by influencing creatine (Cr) metabolism–related and UCP1-dependent thermogenic pathway.

Through in vivo and in vitro experiments, Nishikawa et al. investigated the effect and mechanism of Art-C induced browning of white adipocytes (43). In vitro experiments, Art-C (1–10 μM) significantly increased the mRNA level of brown adipocyte markers and the protein levels of UCP1 and PRDM16 in a dose-dependent manner (43). Further studies found that this significant induction was achieved by activating PPARγ and promoting the stabilization of PRDM16 protein (43). Similarly, in animal experiments, oral administration of Art-C (5 or 10 mg/kg for 4 weeks) can significantly induce brown like adipocytes in mouse inguinal adipose tissue, accompanied by significant expression of UCP1 and PRDM16 proteins, which further verifies the results of in vitro experiments (43). Recently, the same group also found that co-administration of Art-C (5 mg/kg) and curcumin (1.5 mg/kg) synergistically promoted the induction of brown adipocytes in inguinal adipose tissue, and believed that this synergistic effect was associated with norepinephrine produced by murine macrophages (86), but the specific molecular mechanism needs to be further explored. In addition, recent research of Nishikawa team also proposed that Art-C induced thermogenesis is associated with the thermogenesis pathway related to creatine metabolism (39). The research found that Art-C (10 mg/kg, 28 days) significantly induces the thermogenesis of beige adipocytes in inguinal adipose tissue. However, this induction effect is blocked by creatine metabolism inhibitors, indicating that Art-C may achieve energy consumption by significantly up regulating the expression of enzymes related to creatine metabolism in thermogenesis pathway (39). However, the relative contributions of UCP1-dependent and Cr-metabolism-related pathways to the observed Art-C-induced thermogenesis remain unclear. Further studies and mechanism investigations are needed to clarify the intrinsic relationship between Art-C and the two pathways, and UCP1-KO and WAT-specific GATM KO mice may be a powerful tool for subsequent studies (87).

3.4. Regulate the structure and metabolism of gut microbes

Gut microbiota are considered to be a metabolic “organ” involved in regulating energy balance, sugar and lipid metabolism (88, 89), and there is increasing evidence that microbiota regulation is associated with obesity (90). Polyphenolic compounds have been shown to have a very low absorption rate in the front end of the gut, only 5%–10%, and the rest of the unabsorbed polyphenols (90%–95%) reach the colon in high concentrations, where they are broken down by the gut microbiota and degraded into smaller phenolic compounds, which further exert a series of biological effects (91, 92). Therefore, polyphenolic compounds may exert biological effects such as regulating sugar and lipid metabolism, antioxidant and anti-inflammatory by regulating the composition and metabolism of gut microbiota (92–94). So, as the most abundant component in propolis, do propolis polyphenols exert anti-obesity effects by regulating intestinal microbes?

A few studies suggest that the anti-obesity effects of polyphenols in propolis may be related to changes in the gut microbiome (Table 1). Roquetto et al. investigated the effects of green propolis on gut microbiota composition and anti-inflammatory effects in mice fed a high-fat diet, and found that 0.2% crude propolis repaired high-fat diet-induced gut microbial disturbances and reduced circulating LPS levels and inflammatory response (72). Similarly, another study suggested that propolis may mediate anti-obesity effects by modulating gut microbiota composition and function (73). The study found that dietary supplementation with 1% or 2% ethanol extract of propolis reduced high-fat diet-induced weight gain and hepatic fat accumulation. Besides, it improved glucose tolerance and lipid profile, accompanied by an increase in anti-obesity and anti-inflammatory bacteria, such as Intestinimonas genera and Parabacteroides distasonis species and a decrease in pro-inflammatory bacteria, such as Faecalibaculum genera and Bacteroides vulgatus species (73). Recent study using Db/Db mice reported propolis can improve sarcopenic obesity by regulating lipid metabolism disorder and inflammation, regulate intestinal microecology, and increase the abundance of intestinal microbiota related to pentose phosphatase pathway and glycerol metabolism (75). Furthermore, a recent study first reported the therapeutic effect of Chinese propolis (CP) on obesity, and the results showed that dietary CP supplementation significantly improved obesity-related physiological indicators such as weight gain, insulin resistance, hepatic steatosis and triglyceride accumulation (62). Interestingly, the effect of CP on the microbiome structure and metabolism of mice varied by gender (62). It was found that, regardless of gender, CP significantly reduced the abundance of Alistipes, which is the main producer of LPS in mice, but only increased Lactobacillus and the level of propionic acid in male mice (62). In addition to the structure of intestinal microorganisms, the change of its metabolite short chain fatty acids (SCFA) is also very important for obesity (95). SCFA is absorbed in the intestine and plays a regulatory role in intestinal physiology, metabolism and immunity as a regulator of energy intake and inflammation (96). A recent study determined the effects of poplar propolis polyphenol mixtures on the composition and function of gut microbiota obtained from the stools of five different donors, including obese children (74). The results showed that propolis could significantly increase total gut microbial SCFA production in obese children, but did not result in a significant increase in propionic acid concentrations (74). Previous studies have shown that higher concentrations of propionic acid are associated with higher android-to-gynoid fat ratio, which is a risk factor for children’s metabolism and cardiovascular disease (97). Propolis polyphenol does not lead to propionic acid concentration, suggesting that propolis may play a protective role in obese subjects, or at least not worsen the situation (74). However, further studies are needed to understand how propolis polyphenols exert their anti-obesity effects by regulating the structure and metabolism of gut microbiota. A recent study has elucidated the therapeutic effect of CAPE on nonalcoholic fatty liver disease (NAFLD) through the regulation of gut microbes and its potential mechanism (76). It was found that oral administration CAPE inhibited bile salt hydrolase (BSH) activity by reducing the abundance of BSH-producing bacteria, such as Parabacteroides (76). The inhibition of CAPE in BSH lead to the increase of T-β-MCA, which inhibits intestinal FXR signal, reduces ceramide synthesis and promotes GLP-1 secretion. This pathway has been further verified in intestinal FXR-deficient mice (76). Thus, CAPE improves NAFLD by inhibiting bacterial BSH activity, altering bile acid composition and modulating the intestinal FXR signaling-ceramide axis. Nevertheless, although this study reveals the critical role of the gut microbiota during CAPE treatment, details about how CAPE specifically inhibits bacterial BSH activity and selectively modulates intestinal FXR signaling remain unknown. In addition, although intestinal FXR deficiency is associated with elevated serum GLP-1 levels, earlier studies have reported that TGR5 directly promotes GLP-1 secretion (98, 99), while FXR indirectly regulates GLP-1 secretion through mechanisms that rely on downstream TGR5 signaling. Therefore, more in-depth studies are needed to explore the mechanism of TGR5 in CAPE-mediated upregulation of Gcg and GLP-1.

4. Perspectives

Past studies have accumulated sufficient knowledge on the potential anti-obesity benefits of polyphenols in propolis, but there are still many pressing questions and challenges that need to be addressed.

First, the polyphenolic compounds in propolis, which play a major therapeutic role, are believed to have low toxicity and side effects (100). However, propolis is a complex mixture, albeit purified, so we cannot completely rule out the possibility that propolis could have adverse effects on patients. In fact, a human study has shown that propolis may be a skin allergen (101). To avoid the harmful effects of propolis, comprehensive monitoring of biological effects appears to be important. Unfortunately, there are few studies using omics approaches, such as transcriptomics, proteomics and metabolomics, to investigate the anti-obese effect of propolis polyphenols. According to these methods, researchers can more freely obtain information about the absorption and metabolism of propolis components in the body in experimental models, and to understand the information about the possible adverse effects of propolis components. In addition, omics data may also help to reveal the potential beneficial effects of propolis in obesity models, which may further elucidate the mechanism of action of effector molecules.

Second, in addition to CAPE in poplar propolis and Art-C in Brazilian green propolis, it is necessary to explore new bioactive substances in propolis. For example, besides CAPE, propolis are also very rich in other polyphenols such as p-coumaric acid and pinocembrin (22). It is therefore essential to investigate whether the other phenolic compounds in propolis also exert the same physiological activity. In addition, it may be a new breakthrough to study the combined effects of propolis polyphenolic compounds and other sources of phenolics. For example, Nishikawa’s team found that the combination of Art-C and curcumin induced the formation of beige adipocytes more strongly than Art-C or curcumin alone (86).

Finally, current research on the therapeutic effect of polyphenols in propolis on obesity is limited to animals and cell models. Therefore, clinical trials of the anti-obese effect of polyphenols in propolis are necessary.

5. Conclusion

Propolis is a resinous substance that bees collect to build and adapt their nests. Propolis is gaining popularity as a health supplement and is used in fields such as food, beverages, and folk medicine to improve health and prevent diseases such as obesity, diabetes, inflammation, and cancer. Propolis polyphenols are the key active components in propolis. In most cases, propolis polyphenols vary by different origins and plant sources, resulting in different pharmacological activities of these different types of propolis. Propolis polyphenols have superior weight loss activity. Currently, CAPE in poplar propolis and Art-C in Brazilian green propolis are the most widely studied anti-obesity components in propolis. Together, the anti-obesity mechanism of propolis and its derivatives mainly involving the following mechanisms, (I) reducing lipid accumulation and promoting lipid metabolism; (II) inhibiting adipogenesis by hindering adipocyte cycle progression and affecting the expression of adipokines; (III) inducing the transformation of white adipocytes into brown/beige fat cells, and promoting adipocyte thermogenesis by influencing creatine related metabolism and UCP1 dependent thermogenesis; (IV) regulating the structure and metabolism of gut microbes. In addition, PPAR γ plays a crucial role in the anti-obesity effect of polyphenols in propolis.

Author contributions

JZ, HY, and GL: conceptualization. LZ: writing—original draft preparation. BZ, HL, and ZD: writing—review and editing. All authors contributed to the article and approved the submitted version.

Funding

This work was financially supported by the Nanchang Science and Technology Talent Program Hongke Zi [2021] no. 185.

Conflict of interest

JZ, HY, and GL were employed by Nanchang Concentric Purple Nest Biological Engineering Co., Ltd.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Tsai, AG, Williamson, DF, and Ha, G. Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obes Rev. (2011) 12:50–61. doi: 10.1111/j.1467-789X.2009.00708.x

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Jastreboff, AM, Kotz, CM, Kahan, S, Kelly, AS, and Heymsfield, SB. Obesity as a disease: the Obesity Society 2018 position statement. Obesity. (2019) 27:7–9. doi: 10.1002/oby.22378

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Wang, J, and Jia, H. Metagenome-wide association studies: fine-mining the microbiome. Nat Rev Microbiol. (2016) 14:508–22. doi: 10.1038/nrmicro.2016.83

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Okamura, T, Hashimoto, Y, Hamaguchi, M, Obora, A, Kojima, T, and Fukui, M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes. (2019) 43:139–48. doi: 10.1038/s41366-018-0076-3

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Lavie, CJ, McAuley, PA, Church, TS, Milani, RV, and Blair, SN. Obesity and cardiovascular diseases. J Am Coll Cardiol. (2014) 63:1345–54. doi: 10.1016/j.jacc.2014.01.022

CrossRef Full Text | Google Scholar

6. Basen-Engquist, K, and Chang, M. Obesity and cancer risk: recent review and evidence. Curr Oncol Rep. (2011) 13:71–6. doi: 10.1007/s11912-010-0139-7

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Seravalle, G, and Grassi, G. Obesity and hypertension. Pharmacol Res. (2017) 122:1–7. doi: 10.1016/j.phrs.2017.05.013

CrossRef Full Text | Google Scholar

8. Bajari, TM, Nimpf, J, and Schneider, WJ. Role of leptin in reproduction. Curr Opin Lipidol. (2004) 15:315–9. doi: 10.1097/00041433-200406000-00012

CrossRef Full Text | Google Scholar

9. Bray, GA, Fruhbeck, G, Ryan, DH, and Wilding, JPH. Management of obesity. Lancet. (2016) 387:1947–56. doi: 10.1016/s0140-6736(16)00271-3

CrossRef Full Text | Google Scholar

10. Hassan, HA, and El-Gharib, NE. Obesity and clinical riskiness relationship: therapeutic management by dietary antioxidant supplementation—a review. Appl Biochem Biotechnol. (2015) 176:647–69. doi: 10.1007/s12010-015-1602-6

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Sforcin, JM. Biological properties and therapeutic applications of Propolis. Phytother Res. (2016) 30:894–905. doi: 10.1002/ptr.5605

CrossRef Full Text | Google Scholar

12. Irigoiti, Y, Navarro, A, Yamul, D, Libonatti, C, Tabera, A, and Basualdo, M. The use of propolis as a functional food ingredient: a review. Trends Food Sci Technol. (2021) 115:297–306. doi: 10.1016/j.tifs.2021.06.041

CrossRef Full Text | Google Scholar

13. Balica, G, Vostinaru, O, Stefanescu, C, Mogosan, C, Iaru, I, Cristina, A, et al. Potential role of Propolis in the prevention and treatment of metabolic diseases. PLANTS-BASEL. (2021) 10:883. doi: 10.3390/plants10050883

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Tsuda, T, and Kumazawa, S. Propolis: chemical constituents, plant origin, and possible role in the prevention and treatment of obesity and diabetes. J Agric Food Chem. (2021) 69:15484–94. doi: 10.1021/acs.jafc.1c06194

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Natsir, R, Usman, AN, Ardyansyah, BD, and Fendi, F. Propolis and honey trigona decrease leptin levels of central obesity patients. Enferm Clin. (2020) 30:96–9. doi: 10.1016/j.enfcli.2019.07.043

CrossRef Full Text | Google Scholar

16. El-Guendouz, S, Lyoussi, B, and Miguel, MG. Insight on Propolis from Mediterranean countries: chemical composition, biological activities and application fields. Chem Biodivers. (2019) 16:e1900094. doi: 10.1002/cbdv.201900094

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Anjum, SI, Ullah, A, Khan, KA, Attaullah, M, Khan, H, Ali, H, et al. Composition and functional properties of propolis (bee glue): a review. Saudi J Biol Sci. (2019) 26:1695–703. doi: 10.1016/j.sjbs.2018.08.013

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Huang, S, Zhang, C-P, Wang, K, Li, GQ, and Hu, F-L. Recent advances in the chemical composition of Propolis. Molecules. (2014) 19:19610–32. doi: 10.3390/molecules191219610

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Bankova, V, Popova, M, and Trusheva, B. The phytochemistry of the honeybee. Phytochemistry. (2018) 155:1–11. doi: 10.1016/j.phytochem.2018.07.007

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Bankova, VS, de Castro, SL, and Marcucci, MC. Propolis: recent advances in chemistry and plant origin. Apidologie. (2000) 31:3–15. doi: 10.1051/apido:2000102

CrossRef Full Text | Google Scholar

21. Ristivojevic, P, Trifkovic, J, Andric, F, and Miojkovic-Opsenica, D. Poplar-type Propolis: chemical composition, botanical origin and biological activity. Nat Prod Commun. (2015) 10:1934578X1501001–876. doi: 10.1177/1934578X1501001117

CrossRef Full Text | Google Scholar

22. Boisard, S, Le Ray, A-M, Gatto, J, Aumond, M-C, Blanchard, P, Derbre, S, et al. Chemical composition, antioxidant and anti-AGEs activities of a French poplar type Propolis. J Agric Food Chem. (2014) 62:1344–51. doi: 10.1021/jf4053397

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Xu, J, Ge, J, He, X, Sheng, Y, Zheng, S, Zhang, C, et al. Caffeic acid reduces body weight by regulating gut microbiota in diet-induced-obese mice. J Funct Foods. (2020) 74:104061. doi: 10.1016/j.jff.2020.104061

CrossRef Full Text | Google Scholar

24. Liao, C-C, Ou, T-T, Wu, C-H, and Wang, C-J. Prevention of diet-induced hyperlipidemia and obesity by Caffeic acid in C57BL/6 mice through regulation of hepatic lipogenesis gene expression. J Agric Food Chem. (2013) 61:11082–8. doi: 10.1021/jf4026647

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Han, X, Guo, J, You, Y, Zhan, J, and Huang, W. P-Coumaric acid prevents obesity via activating thermogenesis in brown adipose tissue mediated by mTORC1-RPS6. FASEB J. (2020) 34:7810–24. doi: 10.1096/fj.202000333R

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Taysi, S, Demir, E, Cinar, K, and Tarakcioglu, M. The Radioprotective effects of Propolis and Caffeic acid Phenethyl Ester on radiation-induced oxidative/nitrosative stress in brain tissue. Free Radic Biol Med. (2016) 100:S111. doi: 10.1016/j.freeradbiomed.2016.10.286

CrossRef Full Text | Google Scholar

27. Nie, J, Chang, Y, Li, Y, Zhou, Y, Qin, J, Sun, Z, et al. Caffeic acid Phenethyl Ester (Propolis extract) ameliorates insulin resistance by inhibiting JNK and NF-κB inflammatory pathways in diabetic mice and HepG2 cell models. J Agric Food Chem. (2017) 65:9041–53. doi: 10.1021/acs.jafc.7b02880

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Shin, SH, Seo, SG, Min, S, Yang, H, Lee, E, Son, JE, et al. Caffeic acid Phenethyl Ester, a major component of Propolis, suppresses high fat diet-induced obesity through inhibiting Adipogenesis at the mitotic clonal expansion stage. J Agric Food Chem. (2014) 62:4306–12. doi: 10.1021/jf405088f

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Cardinault, N, Tourniaire, F, Astier, J, Couturier, C, Bonnet, L, Seipelt, E, et al. Botanic origin of Propolis extract powder drives contrasted impact on Diabesity in high-fat-fed mice. Antioxidants. (2021) 10:411. doi: 10.3390/antiox10030411

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Juman, S, Yasui, N, Okuda, H, Ueda, A, Negishi, H, Miki, T, et al. Caffeic acid Phenethyl Ester inhibits differentiation to adipocytes in 3T3-L1 mouse fibroblasts. Biol Pharm Bull. (2010) 33:1484–8. doi: 10.1248/bpb.33.1484

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Juman, S, Yasui, N, Okuda, H, Ueda, A, Negishi, H, Miki, T, et al. Caffeic acid Phenethyl Ester suppresses the production of Adipocytokines, leptin, tumor necrosis factor -alpha and Resistin, during differentiation to adipocytes in 3T3-L1 cells. Biol Pharm Bull. (2011) 34:490–4. doi: 10.1248/bpb.34.490

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Pai, SA, Martis, EA, Munshi, RP, Gursahani, MS, Mestry, SN, and Juvekar, AR. Chrysin mitigated obesity by regulating energy intake and expenditure in rats. J Tradit Complement Med. (2020) 10:577–85. doi: 10.1016/j.jtcme.2019.09.002

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Kumar, S, and Alagawadi, KR. Anti-obesity effects of galangin, a pancreatic lipase inhibitor in cafeteria diet fed female rats. Pharm Biol. (2013) 51:607–13. doi: 10.3109/13880209.2012.757327

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Su, T, Huang, C, Yang, C, Jiang, T, Su, J, Chen, M, et al. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity. Pharmacol Res. (2020) 152:104586. doi: 10.1016/j.phrs.2019.104586

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Su, L, Zeng, Y, Li, G, Chen, J, and Chen, X. Quercetin improves high-fat diet-induced obesity by modulating gut microbiota and metabolites in C57BL/6J mice. Phytother Res. (2022) 36:4558–72. doi: 10.1002/ptr.7575

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Marostica, MR Jr, Daugsch, A, Moraes, CS, Queiroga, CL, Pastore, GM, and Park, YK. Comparison of volatile and polyphenolic compounds in Brazilian green propolis and its botanical origin Baccharis dracunculifolia. Ciencia E Tecnologia De Alimentos. (2008) 28:178–81. doi: 10.1590/s0101-20612008000100026

CrossRef Full Text | Google Scholar

37. Kumazawa, S, Yoneda, M, Shibata, I, Kanaeda, J, Hamasaka, T, and Nakayama, T. Direct evidence for the plant origin of Brazilian Propolis by the observation of honeybee behavior and phytochemical analysis. Chem Pharm Bull. (2003) 51:740–2. doi: 10.1248/cpb.51.740

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Rajan, M, Batista, TDC, de Oliveira, CS, de Oliveira, DG, and Narain, N. Optimization of solvent extraction and HPLC-DAD method parameters for determination of phenolic compounds in various Brazilian propolis. J Apic Res. (2021):1–14. doi: 10.1080/00218839.2021.1996111

CrossRef Full Text | Google Scholar

39. Nishikawa, S, Hydo, T, Aoyama, H, Miyata, R, Kumazawa, S, and Tsuda, T. Artepillin C, a key component of Brazilian Propolis, induces thermogenesis in inguinal white adipose tissue of mice through a Creatine-metabolism-related thermogenic pathway. J Agric Food Chem. (2020) 68:1007–14. doi: 10.1021/acs.jafc.9b07080

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Szliszka, E, Mertas, A, Czuba, ZP, and Krol, W. Inhibition of inflammatory response by Artepillin C in activated RAW264.7 macrophages. Evid Based Complement Alternat Med. (2013) 2013:1–11. doi: 10.1155/2013/735176

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Costa, P, Almeida, MO, Lemos, M, Arruda, C, Casoti, R, Somensi, LB, et al. Artepillin C, drupanin, aromadendrin-4’-O-methyl-ether and kaempferide from Brazilian green propolis promote gastroprotective action by diversified mode of action. J Ethnopharmacol. (2018) 226:82–9. doi: 10.1016/j.jep.2018.08.006

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Cheung, K-W, Sze, DM-Y, Chan, WK, Deng, R-X, Tu, W, and Chan, GC-F. Brazilian green propolis and its constituent, Artepillin C inhibits allogeneic activated human CD4 T cells expansion and activation. J Ethnopharmacol. (2011) 138:463–71. doi: 10.1016/j.jep.2011.09.031

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Nishikawa, S, Aoyama, H, Kamiya, M, Higuchi, J, Kato, A, Soga, M, et al. Artepillin C, a typical Brazilian Propolis-derived component, induces Brown-like adipocyte formation in C3H10T1/2 cells, primary inguinal white adipose tissue-derived adipocytes, and mice. PLoS One. (2016) 11:e0162512. doi: 10.1371/journal.pone.0162512

PubMed Abstract | CrossRef Full Text | Google Scholar

44. He, X, Zheng, S, Sheng, Y, Miao, T, Xu, J, Xu, W, et al. Chlorogenic acid ameliorates obesity by preventing energy balance shift in high-fat diet induced obese mice. J Sci Food Agric. (2021) 101:631–7. doi: 10.1002/jsfa.10675

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Cho, A-S, Jeon, S-M, Kim, M-J, Yeo, J, Seo, K-I, Choi, M-S, et al. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol. (2010) 48:937–43. doi: 10.1016/j.fct.2010.01.003

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Lotti, C, Campo Fernandez, M, Piccinelli, AL, Cuesta-Rubio, O, Marquez Hernandez, I, and Rastrelli, L. Chemical constituents of red Mexican Propolis. J Agric Food Chem. (2010) 58:2209–13. doi: 10.1021/jf100070w

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Mendonca-Melo, L, Mota, E, Lopez, B, Sawaya, A, Freitas, L, Jain, S, et al. Chemical and genetic similarity between Dalbergia ecastaphyllum and red propolis from the northeastern Brazil. J Apic Res. (2017) 56:32–9. doi: 10.1080/00218839.2016.1277603

CrossRef Full Text | Google Scholar

48. Piccinelli, AL, Lotti, C, Campone, L, Cuesta-Rubio, O, Fernandez, MC, and Rastrelli, L. Cuban and Brazilian red Propolis: botanical origin and comparative analysis by high-performance liquid chromatography-photodiode Array detection/electrospray ionization tandem mass spectrometry. J Agric Food Chem. (2011) 59:6484–91. doi: 10.1021/jf201280z

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Daugsch, A, Moraes, CS, Fort, P, and Park, YK. Brazilian red Propolis—chemical composition and botanical origin. Evid Based Complement Alternat Med. (2008) 5:754625:435–41. doi: 10.1093/ecam/nem057

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Salatino, A. Brazilian red Propolis: legitimate name of the plant resin source. MOJ Food Process Technol. (2018) 6:21–2. doi: 10.15406/mojfpt.2018.06.00139

CrossRef Full Text | Google Scholar

51. Ccana-Ccapatinta, GV, Aldana Mejia, JA, Tanimoto, MH, Groppo, M, de Carvalho, JCAS, and Bastos, JK. Dalbergia ecastaphyllum (L.) Taub. and Symphonia globulifera L.f.: The botanical sources of Isoflavonoids and benzophenones in Brazilian red Propolis. Molecules. (2020) 25:2060. doi: 10.3390/molecules25092060

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Rufatto, LC, dos Santos, DA, Marinho, F, Pegas Henriques, JA, Ely, MR, and Moura, S. Red propolis: chemical composition and pharmacological activity. Asian Pac J Trop Biomed. (2017) 7:591–8. doi: 10.1016/j.apjtb.2017.06.009

CrossRef Full Text | Google Scholar

53. Bueno-Silva, B, Marsola, A, Ikegaki, M, Alencar, SM, and Rosalen, PL. The effect of seasons on Brazilian red propolis and its botanical source: chemical composition and antibacterial activity. Nat Prod Res. (2017) 31:1318–24. doi: 10.1080/14786419.2016.1239088

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Iio, A, Ohguchi, K, Inoue, H, Maruyama, H, Araki, Y, Nozawa, Y, et al. Ethanolic extracts of Brazilian red propolis promote adipocyte differentiation through PPARγ activation. Phytomedicine. (2010) 17:974–9. doi: 10.1016/j.phymed.2010.03.001

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Lopez, BGC, de Lourenco, CC, Alves, DA, Machado, D, Lancellotti, M, and Sawaya, ACHF. Antimicrobial and cytotoxic activity of red propolis: an alert for its safe use. J Appl Microbiol. (2015) 119:677–87. doi: 10.1111/jam.12874

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Prata, MF, de Carvalho, FMA, Gonçalves-Júnior, WD, Santos, TS, Valois, RBV, Borges, AFS, et al. Hypolipidemic and anti-obesity effects of Hydroalcoholic extract of Brazilian red Propolis in a rodent model of dyslipidemia. Eur J Lipid Sci Technol. (2022) 124:2100017. doi: 10.1002/ejlt.202100017

CrossRef Full Text | Google Scholar

57. Ichi, I, Hori, H, Takashima, Y, Adachi, N, Kataoka, R, Okihara, K, et al. The beneficial effect of Propolis on fat accumulation and lipid metabolism in rats fed a high-fat diet. J Food Sci. (2009) 74:H127–31. doi: 10.1111/j.1750-3841.2009.01147.x

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Sakai, T, Ohhata, M, Fujii, M, Oda, S, Kusaka, Y, Matsumoto, M, et al. Brazilian green Propolis promotes weight loss and reduces fat accumulation in C57BL/6 mice fed a high-fat diet. Biol Pharm Bull. (2017) 40:391–5. doi: 10.1248/bpb.b16-00577

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Koya-Miyata, S, Arai, N, Mizote, A, Taniguchi, Y, Ushio, S, Iwaki, K, et al. Propolis prevents diet-induced hyperlipidemia and mitigates weight gain in diet-induced obesity in mice. Biol Pharm Bull. (2009) 32:2022–8. doi: 10.1248/bpb.32.2022

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Kitamura, H, Naoe, Y, Kimura, S, Miyamoto, T, Okamoto, S, Toda, C, et al. Beneficial effects of Brazilian propolis on type 2 diabetes in Ob/Ob mice: possible involvement of immune cells in mesenteric adipose tissue. Adipocytes. (2013) 2:227–36. doi: 10.4161/adip.25608

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Orsolic, N, Jurcevic, IL, Dikic, D, Rogic, D, Odeh, D, Balta, V, et al. Effect of Propolis on diet-induced hyperlipidemia and Atherogenic indices in mice. Antioxidants. (2019) 8:156. doi: 10.3390/antiox8060156

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Zheng, Y, Wu, Y, Tao, L, Chen, X, Jones, TJ, Wang, K, et al. Chinese Propolis prevents obesity and metabolism syndromes induced by a high fat diet and accompanied by an altered gut microbiota structure in mice. Nutrients. (2020) 12:959. doi: 10.3390/nu12040959

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Chen, Y, Wang, J, Wang, Y, Wang, P, Zhou, Z, Wu, R, et al. A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREB/CRTC2 transcriptional complex. Nat Commun. (2022) 13:13. doi: 10.1038/s41467-021-27533-9

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Washio, K, Shimamoto, Y, and Kitamura, H. Brazilian propolis extract increases leptin expression in mouse adipocytes. Biomed Res. (2015) 36:343–6. doi: 10.2220/biomedres.36.343

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Vanella, L, Tibullo, D, Godos, J, Pluchinotta, FR, Di Giacomo, C, Sorrenti, V, et al. Caffeic acid Phenethyl Ester regulates PPAR’s levels in stem cells-derived adipocytes. PPAR Res. (2016) 2016:1–13. doi: 10.1155/2016/7359521

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Sáinz, N, Barrenetxe, J, Moreno-Aliaga, MJ, and Martínez, JA. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism. (2015) 64:35–46. doi: 10.1016/j.metabol.2014.10.015

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Ikeda, R, Yanagisawa, M, Takahashi, N, Kawada, T, Kumazawa, S, Yamaotsu, N, et al. Brazilian propolis-derived components inhibit TNF-α-mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochim Biophys Acta Gen Subj. (2011) 1810:695–703. doi: 10.1016/j.bbagen.2011.04.007

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Choi, S-S, Cha, B-Y, Iida, K, Lee, Y-S, Yonezawa, T, Teruya, T, et al. Artepillin C, as a PPARγ ligand, enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Biochem Pharmacol. (2011) 81:925–33. doi: 10.1016/j.bcp.2011.01.002

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Cardinault, N, Tourniaire, F, Astier, J, Couturier, C, Perrin, E, Dalifard, J, et al. Poplar Propolis Ethanolic extract reduces body weight gain and glucose metabolism disruption in high-fat diet-fed mice. Mol Nutr Food Res. (2020) 64:2000275. doi: 10.1002/mnfr.202000275

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Amir Siddiqui, M, Badruddeen, J, Akhtar, S, Uddin, SM, Chandrashekharan, M, Ahmad, MIK, et al. Chrysin modulates protein kinase IKK epsilon/TBK1, insulin sensitivity and hepatic fatty infiltration in diet-induced obese mice. Drug Dev Res. (2022) 83:194–207. doi: 10.1002/ddr.21859

CrossRef Full Text | Google Scholar

71. Soleimani, D, Miryan, M, Hadi, V, Gholizadeh Navashenaq, J, Moludi, J, Sayedi, SM, et al. Effect of propolis supplementation on athletic performance, body composition, inflammation, and oxidative stress following intense exercise: a triple-blind randomized clinical trial. Food Sci Nutr. (2021) 9:3631–40. doi: 10.1002/fsn3.2319

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Roquetto, AR, Santana Monteiro, NE, Moura, CS, Toreti, VC, de Pace, F, dos Santos, A, et al. Green propolis modulates gut microbiota, reduces endotoxemia and expression of TLR4 pathway in mice fed a high-fat diet. Food Res Int. (2015) 76:796–803. doi: 10.1016/j.foodres.2015.07.026

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Cai, W, Xu, J, Li, G, Liu, T, Guo, X, Wang, H, et al. Ethanol extract of propolis prevents high-fat diet-induced insulin resistance and obesity in association with modulation of gut microbiota in mice. Food Res Int. (2020) 130:108939. doi: 10.1016/j.foodres.2019.108939

PubMed Abstract | CrossRef Full Text | Google Scholar

74. Garzarella, EU, Navajas-Porras, B, Pérez-Burillo, S, Ullah, H, Esposito, C, Santarcangelo, C, et al. Evaluating the effects of a standardized polyphenol mixture extracted from poplar-type propolis on healthy and diseased human gut microbiota. Biomed Pharmacother. (2022) 148:112759. doi: 10.1016/j.biopha.2022.112759

PubMed Abstract | CrossRef Full Text | Google Scholar

75. Okamura, T, Hamaguchi, M, Bamba, R, Nakajima, H, Yoshimura, Y, Kimura, T, et al. Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity. J Cachexia Sarcopenia Muscle. (2022) 13:3028–47. doi: 10.1002/jcsm.13076

PubMed Abstract | CrossRef Full Text | Google Scholar

76. Zhong, X-C, Liu, Y-M, Gao, X-X, Krausz, KW, Niu, B, Gonzalez, FJ, et al. Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity. Acta Pharmacol Sin. (2022) 44:145–56. doi: 10.1038/s41401-022-00921-7

PubMed Abstract | CrossRef Full Text | Google Scholar

77. Choi, SM, Tucker, DF, Gross, DN, Easton, RM, DiPilato, LM, Dean, AS, et al. Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Mol Cell Biol. (2010) 30:5009–20. doi: 10.1128/MCB.00797-10

PubMed Abstract | CrossRef Full Text | Google Scholar

78. Park, H-K, and Ahima, RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism-Clin Exp. (2015) 64:24–34. doi: 10.1016/j.metabol.2014.08.004

PubMed Abstract | CrossRef Full Text | Google Scholar

79. Miki, H, Yamauchi, T, Suzuki, R, Komeda, K, Tsuchida, A, Kubota, N, et al. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. Mol Cell Biol. (2001) 21:2521–32. doi: 10.1128/MCB.21.7.2521-2532.2001

PubMed Abstract | CrossRef Full Text | Google Scholar

80. Berg, AH, Combs, TP, and Scherer, PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. (2002) 13:84–9. doi: 10.1016/S1043-2760(01)00524-0

PubMed Abstract | CrossRef Full Text | Google Scholar

81. Cannon, B, and Nedergaard, J. Brown adipose tissue: function and physiological significance. Physiol Rev. (2004) 84:277–359. doi: 10.1152/physrev.00015.2003

CrossRef Full Text | Google Scholar

82. Seale, P, Bjork, B, Yang, W, Kajimura, S, Chin, S, Kuang, S, et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature. (2008) 454:961–7. doi: 10.1038/nature07182

PubMed Abstract | CrossRef Full Text | Google Scholar

83. Giralt, M, and Villarroya, F. White, Brown, beige/Brite: different adipose cells for different functions? Endocrinology. (2013) 154:2992–3000. doi: 10.1210/en.2013-1403

PubMed Abstract | CrossRef Full Text | Google Scholar

84. Nedergaard, J, and Cannon, B. The changed metabolic world with human Brown adipose tissue: therapeutic visions. Cell Metab. (2010) 11:268–72. doi: 10.1016/j.cmet.2010.03.007

PubMed Abstract | CrossRef Full Text | Google Scholar

85. Yoneshiro, T, Aita, S, Matsushita, M, Kameya, T, Nakada, K, Kawai, Y, et al. Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity. (2011) 19:13–6. doi: 10.1038/oby.2010.105

PubMed Abstract | CrossRef Full Text | Google Scholar

86. Nishikawa, S, Kamiya, M, Aoyama, H, Yoshimura, K, Miyata, R, Kumazawa, S, et al. Co-Administration of Curcumin and Artepillin C Induces Development of Brown-like adipocytes in association with local norepinephrine production by alternatively activated macrophages in mice. J Nutr Sci Vitaminol. (2019) 65:328–34. doi: 10.3177/jnsv.65.328

PubMed Abstract | CrossRef Full Text | Google Scholar

87. Kazak, L, Chouchani, ET, Lu, GZ, Jedrychowski, MP, Bare, CJ, Mina, AI, et al. Genetic depletion of adipocyte Creatine metabolism inhibits diet-induced thermogenesis and drives obesity. Cell Metab. (2017) 26:660–671.e3. doi: 10.1016/j.cmet.2017.08.009

PubMed Abstract | CrossRef Full Text | Google Scholar

88. Tremaroli, V, and Backhed, F. Functional interactions between the gut microbiota and host metabolism. Nature. (2012) 489:242–9. doi: 10.1038/nature11552

CrossRef Full Text | Google Scholar

89. Zhao, L. The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol. (2013) 11:639–47. doi: 10.1038/nrmicro3089

CrossRef Full Text | Google Scholar

90. Clarke, SF, Murphy, EF, O’Sullivan, O, Ross, RP, O’Toole, PW, Shanahan, F, et al. Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS One. (2013) 8:e65790. doi: 10.1371/journal.pone.0065790

PubMed Abstract | CrossRef Full Text | Google Scholar

91. Stevens, JF, and Maier, CS. The chemistry of gut microbial metabolism of polyphenols. Phytochem Rev. (2016) 15:425–44. doi: 10.1007/s11101-016-9459-z

PubMed Abstract | CrossRef Full Text | Google Scholar

92. Pimpao, RC, Ventura, MR, Ferreira, RB, Williamson, G, and Santos, CN. Phenolic sulfates as new and highly abundant metabolites in human plasma after ingestion of a mixed berry fruit puree. Br J Nutr. (2015) 113:454–63. doi: 10.1017/s0007114514003511

PubMed Abstract | CrossRef Full Text | Google Scholar

93. Gao, X, Xie, Q, Kong, P, Liu, L, Sun, S, Xiong, B, et al. Polyphenol- and caffeine-rich Postfermented Pu-erh tea improves diet-induced metabolic syndrome by remodeling intestinal homeostasis in mice. Infect Immun. (2018) 86:e00601–17. doi: 10.1128/iai.00601-17

PubMed Abstract | CrossRef Full Text | Google Scholar

94. Anhe, FF, Roy, D, Pilon, G, Dudonne, S, Matamoros, S, Varin, TV, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. (2015) 64:872–83. doi: 10.1136/gutjnl-2014-307142

PubMed Abstract | CrossRef Full Text | Google Scholar

95. Barbara, G, Feinle-Bisset, C, Ghoshal, UC, Santos, J, Vanner, SJ, Vergnolle, N, et al. The intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology. (2016) 150:1305–1318.e8. doi: 10.1053/j.gastro.2016.02.028

CrossRef Full Text | Google Scholar

96. Koh, A, De Vadder, F, Kovatcheva-Datchary, P, and Bäckhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cells. (2016) 165:1332–45. doi: 10.1016/j.cell.2016.05.041

PubMed Abstract | CrossRef Full Text | Google Scholar

97. Wei, Y, Liang, J, Su, Y, Wang, J, Amakye, WK, Pan, J, et al. The associations of the gut microbiome composition and short-chain fatty acid concentrations with body fat distribution in children. Clin Nutr. (2021) 40:3379–90. doi: 10.1016/j.clnu.2020.11.014

PubMed Abstract | CrossRef Full Text | Google Scholar

98. Pathak, P, Liu, H, Boehme, S, Xie, C, Krausz, KW, Gonzalez, F, et al. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism. J Biol Chem. (2017) 292:11055–69. doi: 10.1074/jbc.M117.784322

PubMed Abstract | CrossRef Full Text | Google Scholar

99. Pathak, P, Xie, C, Nichols, RG, Ferrell, JM, Boehme, S, Krausz, KW, et al. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology. (2018) 68:1574–88. doi: 10.1002/hep.29857

PubMed Abstract | CrossRef Full Text | Google Scholar

100. Kitamura, H. Effects of Propolis extract and Propolis-derived compounds on obesity and diabetes: knowledge from cellular and animal models. Molecules. (2019) 24:4394. doi: 10.3390/molecules24234394

PubMed Abstract | CrossRef Full Text | Google Scholar

101. Corazza, M, Borghi, A, Gallo, R, Schena, D, Pigatto, P, Lauriola, MM, et al. Topical botanically derived products: use, skin reactions, and usefulness of patch tests. A multicentre Italian study. Contact Dermatitis. (2014) 70:90–7. doi: 10.1111/cod.12124

PubMed Abstract | CrossRef Full Text | Google Scholar